Generic drugs giant Sandoz said on Wednesday that it had “taken note” of Washington’s announcements regarding new tariffs of up to 200%.
Sandoz "takes note" of the new US tariffs
Keystone-SDA
Generic drugs giant Sandoz said on Wednesday that it had “taken note” of Washington’s announcements regarding new tariffs on this type of medication, adding that it was “still too early” to assess the implications.
This content was published on
July 22, 2026 - 10:15
US President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or…
Sandoz steps up criticism of imports of low-priced antibiotics from China.
L’offensive protectionniste de Donald Trump vise à rapatrier la production de médicaments génériques aux Etats-Unis. Une…
Der führende Generika-Hersteller aus Basel hat bisher darauf verzichtet, neue Fabriken in den USA zu bauen. Die Schweizer…
Dans les années à venir, de nombreux brevets protégeant des médicaments vont expirer. Une aubaine pour le groupe bâlois Sandoz,…
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on August 5.
Generic drugmaker Sandoz to engage with US after Trump tariff threat
Les menaces de Donald Trump sur les génériques placent Sandoz en première ligne - Le Temps
Trump droht jetzt mit Generika-Zöllen von 200 Prozent - auch Sandoz wäre betroffen
Après les médicaments innovants, Trump veut taxer les génériques importés
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
US to impose steep tariffs on generic medicine imports from Aug 2028
US-Zölle: Trump kündigt hohe Zölle auf Generika ab 2028 an
Donald Trump annonce des droits de douane de 100% sur les médicaments génériques à partir d'août 2028 - Le Temps
Pharma companies in a flux over Trump's 200% tariff move on generics
Trump: dazi zero sui generici, poi aumenti massicci - RSI
